AI-CAD-Guided Mammographic Assessment of Tumor Size and T Stage: Concordance with MRI for Clinical Staging in Breast Cancer Patients Considered for NAC
<b>Objectives</b>: To evaluate the agreement between AI-CAD-guided mammographic and MRI measurements of tumor size and T stage in breast cancer patients being considered for neoadjuvant chemotherapy (NAC). <b>Methods</b>: This retrospective study included 144 women (mean age,...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Tomography |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2379-139X/11/7/72 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <b>Objectives</b>: To evaluate the agreement between AI-CAD-guided mammographic and MRI measurements of tumor size and T stage in breast cancer patients being considered for neoadjuvant chemotherapy (NAC). <b>Methods</b>: This retrospective study included 144 women (mean age, 52 ± 11 years) with invasive breast cancer who subsequently received NAC and underwent both AI-CAD mammography (score ≥ 10) and pre-treatment MRI. Tumor sizes from AI-CAD contours were compared with MRI using Pearson correlation, intraclass correlation coefficients (ICCs), and Bland–Altman analysis. Concordance was defined as a ±0.5 cm difference. The contour showing the highest agreement was used to compare T stage with MRI using weighted kappa. <b>Results</b>: The mean AI-CAD abnormality score was 86.3 ± 22.2. Tumor sizes on mammography were 3.0 ± 1.2 cm (inner), 3.8 ± 1.5 cm (middle), and 4.8 ± 2.2 cm (outer), while the MRI-measured tumor size was 4.0 ± 1.9 cm. The middle contour showed the strongest correlation with MRI (r = 0.897; ICC = 0.866), the smallest mean difference (–0.19 cm; limits of agreement, –1.87 to 1.49), and the highest concordance (61.1%). Agreement was higher in mass-only lesions than in NME-involved lesions (ICC = 0.883 vs. 0.775; concordance, 70.9% vs. 46.6%). T stage comparison using the middle contour showed substantial agreement with MRI (κ = 0.743 [95% CI, 0.634–0.852]; agreement, 88.2%), with higher concordance in mass-only lesions (93.0%) than NME-involved lesions (81.0%) and more frequent understaging in the latter (17.2% vs. 2.3%). <b>Conclusions</b>: AI-CAD-guided mammographic assessment using the middle contour demonstrated good agreement with MRI for tumor size and T stage, indicating its value as a supportive tool for clinical staging in MRI-limited settings. |
|---|---|
| ISSN: | 2379-1381 2379-139X |